Nepafenac punctal plug reduces Postop Pain After Cataract Surgery
The topical approach of dispensing drug is the most common drug delivery system for pain management after cataract surgery. However, the topical ocular drug bioavailability is notoriously poor, in the order of 5% or less. A recent study suggests that the nepafenac punctal plug drug delivery system (PPDS) is safe and effective for reducing pain and inflammation associated with cataract surgery. The study findings were published in the Journal of Cataract and Refractory Surgery in the February 2021 issue.
The outcomes in contemporary cataract surgery partially depend on patient compliance. New therapeutic approaches, such as the one presented in this study, represent an appealing alternative. "The nepafenac PPDS simplifies medical management for the elderly patient population and resolves the problems associated with the use of topical medication. It demonstrated unprecedented efficacy in reducing pain and inflammation after cataract surgery in the phase II study." Dr Eric D. Donnenfeld said in an interview.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.